Organization
Centre for Addiction and Mental Health
28 clinical trials
Clinical trial
Remote Treatment of Alcohol Withdrawal: A Pilot StudyStatus: Completed, Estimated PCD: 2023-10-16
Clinical trial
Effects of Antipsychotics on Brain Insulin Action in Females: A Randomised Placebo-Controlled, Crossover Multi-Modal Neuroimaging StudyStatus: Recruiting, Estimated PCD: 2026-03-01
Clinical trial
Does Psilocybin Change Synaptic Density in the Brains of Patients With Amnestic Mild Cognitive ImpairmentStatus: Recruiting, Estimated PCD: 2026-07-01
Clinical trial
The Influence of Age on Driving-related Cannabis Effects: Exploring Cannabis Use Frequency and Related FactorsStatus: Recruiting, Estimated PCD: 2027-03-01
Clinical trial
Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability: A Double-Blind Randomized Control TrialStatus: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
Risk of Breakthrough Symptoms On Antipsychotic Maintenance Medication When Remitted Patients Are Treated With Long-Acting Injectable MedicationsStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in SchizophreniaStatus: Recruiting, Estimated PCD: 2025-04-01
Clinical trial
Nicotine Reinforcement and Smoking-Cue Reactivity: Association With Genetic PolymorphismsStatus: Completed, Estimated PCD: 2019-11-29
Clinical trial
Personalized Dosing of Nicotine Replacement for Smoking Cessation: An Effectiveness Randomized Placebo-controlled TrialStatus: Completed, Estimated PCD: 2023-02-27
Clinical trial
Impact of Chronic Nabilone Self-administration on Body Weight, Metabolic Markers, Gut Microbiota, and Neural Circuitry in Human ObesityStatus: Terminated, Estimated PCD: 2023-08-14
Clinical trial
Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity for Metformin Non-responders: a Single-blind Randomized Control TrialStatus: Recruiting, Estimated PCD: 2025-08-01
Clinical trial
Does Psilocybin Require Psychedelic Effects to Treat Depression? A 4-Week, Double-Blind, Proof-of-Concept Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2026-02-01
Clinical trial
RCT of Neurocognitive and Neuroimaging Biomarkers: Predicting Progression Towards Dementia in Patients With Treatment-resistant Late-life Depression (OPTIMUM-Neuro RCT)Status: Active (not recruiting), Estimated PCD: 2024-04-30
Clinical trial
"Re-examining Maintenance Antipsychotic Treatment in Schizophrenia: "Extended" Antipsychotic Dosing"Status: Recruiting, Estimated PCD: 2027-09-30
Clinical trial
Testing a Novel Therapeutic Strategy for Comorbid Post-Traumatic Stress Disorder and Alcohol Use DisorderStatus: Recruiting, Estimated PCD: 2025-02-01
Clinical trial
Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia: A Pilot, Double-Blind, Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2026-12-01
Clinical trial
Neural Correlates of Anti-suiciDal rEsponse to kEtamine in Treatment Resistant biPolar dePression (DEEPP-Study)Status: Recruiting, Estimated PCD: 2024-02-19
Clinical trial
Is Brain Insulin Resistance a Feature of the Biology of Depression: A Pilot Multi-modality Neuroimaging Study in AdolescentsStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Safety and Clinical Effects of Intranasal Ketamine in Ultra-REsistant Depression (SURE-ECT Non Responders). Pilot StudyStatus: Completed, Estimated PCD: 2023-07-24
Clinical trial
Topiramate in Treatment Refractory Psychotic Illness: Effects on Weight Gain and PsychopathologyStatus: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
Effect of Antipsychotics on Central Insulin Action in Relation to Glucose Metabolism and Cognition in Healthy VolunteersStatus: Recruiting, Estimated PCD: 2024-07-30
Clinical trial
Combined and Separate Effects of Cannabis and Tobacco: Psychomotor, Subjective and Physiological OutcomesStatus: Not yet recruiting, Estimated PCD: 2027-02-01
Clinical trial
Investigating the Effects of Nabilone on Endocannabinoid Metabolism in the Human BrainStatus: Recruiting, Estimated PCD: 2026-10-01
Clinical trial
Evaluating the Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant Obsessive-compulsive Disorder: An Open-label Clinical TrialStatus: Not yet recruiting, Estimated PCD: 2024-06-01
Clinical trial
Deep rTMS and Varenicline for Smoking Cessation: A Pilot Study Exploring the Efficacy of a Combined Treatment ApproachStatus: Completed, Estimated PCD: 2022-09-13
Clinical trial
Cytisine: Testing Its Potential as a Therapeutic Strategy for Smoking Cessation Among People With Concurrent Alcohol Use DisorderStatus: Recruiting, Estimated PCD: 2024-01-01
Clinical trial
Coordinating Smoking Cessation Treatment With Menstrual Cycle Phase to Improve Quit Outcomes: A Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-08-31